<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Even</title>
	<atom:link href="http://www.tapanray.in/tag/even/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Healthcare Malpractice in India: Even Medical Association distastes the ‘Bitter Pill’</title>
		<link>http://www.tapanray.in/healthcare-malpractice-in-india-even-medical-association-distastes-the-bitter-pill/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-malpractice-in-india-even-medical-association-distastes-the-bitter-pill</link>
		<comments>http://www.tapanray.in/healthcare-malpractice-in-india-even-medical-association-distastes-the-bitter-pill/#comments</comments>
		<pubDate>Mon, 11 Jun 2012 00:00:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Association]]></category>
		<category><![CDATA[Bitter]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[distastes]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Malpractice]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pill]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=82</guid>
		<description><![CDATA[At a peak of repeated overdose of media sensationalism covering various facets of happenings around us, at times almost mimicking ‘self-flagellation’ though, the program ‘Satyamev Jayate (Truth Alone Triumphs) ’ of Bollywood icon Aamir Khan has the potential to be &#8230; <a href="http://www.tapanray.in/healthcare-malpractice-in-india-even-medical-association-distastes-the-bitter-pill/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-malpractice-in-india-even-medical-association-distastes-the-bitter-pill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Non-Communicable Diseases (NCD) are hitting the poor even harder, economically: a time to ponder and a time to act</title>
		<link>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act</link>
		<comments>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/#comments</comments>
		<pubDate>Mon, 06 Dec 2010 00:30:39 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[Communicable]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[economically]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[harder]]></category>
		<category><![CDATA[hitting]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[ponder]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=339</guid>
		<description><![CDATA[November 11, 2010 edition of &#8216;The Lancet&#8217; published an article titled, “Raising the priority of preventing chronic diseases: a political process&#8221;. The article enumerated the following: “Chronic diseases, especially cardiovascular diseases, diabetes, cancer, and chronic obstructive respiratory diseases, are neglected &#8230; <a href="http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Access to affordable healthcare to 65% of Indian population still remains a key issue even after six decades of independence of the country.</title>
		<link>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country</link>
		<comments>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/#comments</comments>
		<pubDate>Mon, 12 Apr 2010 01:30:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[65%]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[after]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[decades]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[independence]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[key]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[remains]]></category>
		<category><![CDATA[six]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=442</guid>
		<description><![CDATA[Despite so much of stringent government control, debate and activism on the affordability of modern medicines in India, on the one hand, and the success of the government to make medicines available in the country at a price, which is &#8230; <a href="http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/access-to-affordable-healthcare-to-65-of-indian-population-still-remains-a-key-issue-even-after-six-decades-of-independence-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A global pharmaceutical iconoclast, who sees “Fortune” beyond the creamy top layers of the society … even at the bottom of the Pyramid</title>
		<link>http://www.tapanray.in/a-global-pharmaceutical-iconoclast-who-sees-fortune-beyond-the-creamy-top-layers-of-the-society-even-at-the-bottom-of-the-pyramid/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=a-global-pharmaceutical-iconoclast-who-sees-fortune-beyond-the-creamy-top-layers-of-the-society-even-at-the-bottom-of-the-pyramid</link>
		<comments>http://www.tapanray.in/a-global-pharmaceutical-iconoclast-who-sees-fortune-beyond-the-creamy-top-layers-of-the-society-even-at-the-bottom-of-the-pyramid/#comments</comments>
		<pubDate>Mon, 22 Mar 2010 00:30:22 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[andrew]]></category>
		<category><![CDATA[at]]></category>
		<category><![CDATA[beyond]]></category>
		<category><![CDATA[bottom]]></category>
		<category><![CDATA[creamy]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[Fortune]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[iconoclast]]></category>
		<category><![CDATA[layers]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pyramid]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sees]]></category>
		<category><![CDATA[society]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[top]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[witty]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=451</guid>
		<description><![CDATA[In March 2009 GlaxoSmithKline (GSK) unraveled a path breaking vision, within the global pharmaceutical industry, with the creation of a ‘voluntary patent pool’to spark development of new treatments for neglected diseases of the poorest countries of the world. The head &#8230; <a href="http://www.tapanray.in/a-global-pharmaceutical-iconoclast-who-sees-fortune-beyond-the-creamy-top-layers-of-the-society-even-at-the-bottom-of-the-pyramid/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/a-global-pharmaceutical-iconoclast-who-sees-fortune-beyond-the-creamy-top-layers-of-the-society-even-at-the-bottom-of-the-pyramid/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To prevent ‘counterfeit medicines’ from reaching the patients is the nation&#8217;s public health responsibility: Are we still in a denial mode to even accept the existence of this public health menace?</title>
		<link>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h</link>
		<comments>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 01:00:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[accept]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[denial]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[existence]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[mode]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reaching]]></category>
		<category><![CDATA[responsibility]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[this]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=721</guid>
		<description><![CDATA[In November 7, 2009, Financial Express reported with a headline,”Generic drug companies see a bitter pill in counterfeit&#8220;, because some believe that it has an in-built intellectual property right connotation. The dictionary definition: The word ‘counterfeit’ may be defined as &#8230; <a href="http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Global API manufacturers are poised to penetrate the Indian market in a bigger way – will the API &#8216;marketing warfare&#8217; be even more intense, in future?</title>
		<link>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future</link>
		<comments>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/#comments</comments>
		<pubDate>Mon, 25 May 2009 01:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[bigger]]></category>
		<category><![CDATA[bulk]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[intense]]></category>
		<category><![CDATA[manufacturers]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[penetrate]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[poised]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[warfare]]></category>
		<category><![CDATA[way]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=878</guid>
		<description><![CDATA[India currently plays a relatively dominant role in the Global Active Pharmaceutical Ingredient (API) Market with China being ahead of India. While this is the current scenario, many experts in this field contemplates that important players from the regulated markets &#8230; <a href="http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/global-api-manufacturers-are-poised-to-penetrate-the-indian-market-in-a-bigger-way-will-the-api-marketing-warfare-be-even-more-intense-in-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
